Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol for prevention of contrast-induced nephropathy in adults with renal dysfunction undergoing coronary angiography or PCI
IRCT20160412027346N7Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of calcitriol in contrast-induced nephropathy (CIN) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: cystatin C and glomerular filtration rate. Started Jun 2016; status: completed.
02
Drugs
calcitriol
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT20160412027346N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160412027346N7.